Production of antibody to hepatitis B surface antigen (anti-HBs) by murine hepatitis B virus carriers: Neonatal tolerance versus antigen presentation by dendritic cells

Immunology

Volumn 92, Issue 4, 1997, Pages 494-500

  Kurose, K ^a   Akbar, Sk Md F ^a   Yamamoto, K ^a   Onji, M ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD86 ANTIGEN; GAMMA INTERFERON; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL CELL; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; HEPATITIS B; HEPATITIS B VIRUS; IMMUNOMODULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE; VIRUS HEPATITIS;

EID: 0030834783     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1997.00373.x     Document Type: Article

References (29)

1. BURNET F.M., STONE J.D. & EDEY M. (1950) The failure of antibody production in the chick embryo. Aust J Exp Med 28, 291.
2. BILLINGHAM R.E., BRENT L. & MEDAWAR P.B. (1953) Actively acquired tolerance of foreign cells. Nature 172, 603.
3. PETERS M., VIERLING J., GERSHWIN M.E., MILICH D., CHISARI F.V. & HOOFNAGLE J.H. (1991) Immunology and liver. Hepatology 13, 977.
4. THOMAS H.C., MONTANO L., GOODALI A., DE KONING R., OLADAPO J. & WEIDMAN K.H. (1982) Immunological mechanism in chronic hepatitis B virus infection. Hepatology 2, 116S.
5. THOMAS H.C. (1991) Pathogenesis of chronic HBV infection and mechanisms of action of anti viral compounds. In: Viral Hepatitis and Liver Disease (eds F. B. Hollinger, S. Lemon, H. S. Magolis), p. 612. Williams & WILKINS, BALTIMORE.
6. FERAN A., CAYZER C.J.R. & COOKSLEY W.G.E. (1989) HBsAg-induced antigen-specific T and B lymphocytes responses in chronic hepatitis B virus carriers and immune individuals. Clin Exp Immunol 76, 222.
7. DUSHEIKO G.M., HOOFNAGLE J.H., COOKSLEY W.G., JAMES S.P. & JONES E.A. (1983) Synthesis of antibodies to hepatitis B virus by cultured lymphocytes from chronic hepatitis B surface antigen carriers. J Clin Invest 71, 1104.
8. MILICH D.R., JONES J.E., HUGHES J.L., PRICE J., RANEY A.K. & MCLACHLAN A. (1990) Is a function of the secreted hepatitis Be antigen to induce immunologie tolerance in utero? Proc Natl Acad Sci USA 87, 6599.
9. POL S., DRISS F., MICHEL M., NALPES B., BERTHELOT P. & BRECHOT C. (1994) Specific vaccine therapy in chronic hepatitis B infection. Lancet 344, 342 (letter).
10. WEN Y-M., XIONG S-D. & ZHANG W. (1994) Solid matrix-antibody-antigen complex can clear viraemia and antigenaemia in persistent duck hepatitis B virus infection. J Gen Virol 75, 335.
11. AKBAR S.M.F., KAJINO K., TANIMOTO T. et al. (1997) Placebo-controlled trial of vaccination with hepatitis B virus surface antigen in hepatitis B virus transgenic mice. J Hepatol 26, 131.
12. WEN Y-M., WU X-H., HU D-C., ZHANG Q-P. & GUO S-Q. (1995) Hepatitis B vaccine complex as approach for vaccine therapy. Lancet 345, 1575 (letter).
13. ARAKI K., MIYAZAKI J., HINO O. et al. (1989) Expression and replication of hepatitis B virus genome in transgenic mice. Proc Natl Acad Sci USA 86, 207.
14. ARAKI K., NISHIMURA S., OCHIYA T. et al (1991) Production and effect of infectious Dane particles in transgenic mice. Jpn J Cancer Res 82, 235.
15. AKBAR S.M.F., ONJI M., INABA K., YAMAMURA K. & OHTA Y. (1993) Low responsiveness of hepatitis B virus transgenic mice in antibody response to T-cell-dependent antigen: defect in antigen-presenting activity of dendritic cells. Immunology 78, 468.
16. AKBAR S.M.F., INABA K. & ONJI M. (1996) Upregulation of MHC class II antigen on dendritic cells from hepatitis B virus transgenic mice: abrogation of immune response defect to a T-cell-dependent antigen. Immunology 87, 519.
17. METLAY J.P., WITMER-PACK M.D., AGGER P., CROWLEY M.T., LAWLESS D. & STEINMAN R.M. (1990) The distinct leukocyte integrins of mouse spleen dendritic cells as identified with new hamster monoclonal antibodies. J Exp Med 171, 1753.
18. CROWLEY M., INABA K., WITMAR-PACK M. & STEINMAN RM. (1989) The cell surface of mouse dendritic cells: FACS analyses of dendritic cells from different tissues including thymus. Cell Immunol 118, 1008.
19. YAMAUCHI K., NAKANISHI T., CHIOU S-S. & OBATA H. (1988) Suppression of hepatitis B antibody synthesis by factor made by T cells from chronic hepatitis B carriers. Lancet i, 324.
20. MISHRA A., DURGAPAL H., MANIVEL V., ACHARYA S.K., RAO K.V.S. & PANDA S.K. (1992) Immune response to hepatitis B virus surface antigen peptides during HBV infection. Clin Exp Immunol 90, 194.
21. MACTONIA S.E., PATTERSON S. & KNIGHTS S.C. (1989) Suppression of immune responses by dendritic cells infected with HIV. Immunology 67, 285.
22. GAVRILOVICH D.I, PATTERSON S., HARVEY J.J., WOODS G.M., ELSLEY W. & KNIGHT S.C. (1995) Defects in the function of dendritic cells in murine retroviral infection. Adv Exp Med Biol 378, 469.
23. GRABBE S., BEISSERT S., SCHWARZ T. & GRANSTEIN R.D. (1995) Dendritic cells as initiators of tumor immune response; a possible strategy for immunotherapy? Immunol Today 16, 117.
24. MATZINGER P. (1994) Tolerance, danger and extended family. Annu Rev Immunol 12, 991-1045.
25. RIDGE J.P., FUCHS E.J. & MATZINGER P. (1996) Neonatal tolerance revisited: turning on newborn T cells with dendritic cells. Science 271, 1723.
26. SYLVAN S.P.E., HELLSTROM U.B. & LUNDBERGH P.R. (1985) Detection of cellular and humoral immunity to hepatitis B surface antigen (HBsAg) in asymptomatic HBsAg carriers. Clin Exp Immunol 62, 288.
27. MANCINI M., HADCHOUEL M., TIOLLAIS P., POURCEL C. & MICHEL M.L. (1993) Induction of anti-hepatitis B surface antigen (HBsAg) antibodies in HBsAg producing transgenic mice: a possible way of circumventing 'nonresponse' to HBsAg. J Med Virol 39, 67.
28. WEN Y-M., XIONG S-D. & ZHANG W. (1994) Solid matrix-antibody-antigen complex can clear viraemia and antigenaemia in persistent duck hepatitis B virus. J Gen Virol 75, 335.
29. VITIELLO A., ISHIOKA G., GREY H.M. et al. (1995) Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. 1. Induction of primary cytotoxic T lymphocyte response in humans. J Clin Invest 95, 341.